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Developing better therapies through collegial interaction
The Society for Applied Research in Aging (SARA) was founded to serve the needs 
of practitioners who seek to sustain health, vitality, and quality of life of their patients 
during aging. Recognizing that a most basic and important part of that task is to provide 
relevant professional information to its members, Clinical Interventions in Aging (CIA) 
was created as the ofﬁ  cial SARA journal.
Since age-management practitioners must frequently employ therapies from a 
variety of different disciplines, they often have need for information and methods 
that are outside the scope of their formal training. Recognizing these needs, during 
its ﬁ  rst two years of publication, the staff of CIA has sought reviews and research 
papers from experts in a broad range of ﬁ  elds. Hopefully, these have served to expand 
the knowledge base of its readership and will be a source of continuing education 
for practitioners seeking to better manage the physical and mental problems that are 
associated with advancing age. However, as valuable as reviews and research papers 
may be, they sometimes fail to provide speciﬁ  c and detailed information on a unique 
issues that may be facing one practitioner or another. Alternatively, novel therapies 
may emerge that are promising but for which sufﬁ  cient evidence-based information 
has not yet been gathered and published. For example, hormone replacement therapy 
(HRT) is undeniably the cornerstone of age-management medicine. However, it is 
coming increasingly apparent that while traditional HRT may have many beneﬁ  cial 
effects on somatic structure and perhaps function as well, it does little to restore 
youthful endocrine physiology. To the contrary, because HRT often employs the 
end-products of various neuroendocrine axes, it essentially “short circuits” the system 
it intends to restore. This effect accelerates decay of feedback relationships and of 
functional elements on the cells and tissues they employ. An example of this effect 
involves the use of recombinant human growth hormone (rhGH) which while having 
beneﬁ  cial effects on body composition actually causes disuse atrophy of the pituitary 
gland. Through negative feedback, rhGH reduces pitutiary receptor sensitivity to the 
neurohormone responsible for sustaining production and secretion of endogenous hGH 
and reduces production of endogenous hGH (Crist et al 1988; Horikawa et al 1996). 
Other examples of these biphasic effects of end hormone replacement are becoming 
recognized. This has resulted in search for alternative methods of HRT that bring its 
beneﬁ  ts while minimizing its risks. One approach is an emerging technology tenta-
tively named primary locus intervention (PLI) therapy. Unlike traditional HRT, PLI 
therapy employs methods to rejuvenate and restore feedback relationships as well as 
physiological function of higher order neuroendocrine components while opposing 
the decremental effects of aging on end hormone production and secretion. A common 
example of such a novel intervention is the growing use of growth hormone releasing 
factor (GRF1–29 NH2, sermorelin) for GHRT in age-management (Walker 2006). Even 
more recently, compounds that enhance the inﬂ  uence of brain monoamine neurotrans-
mitters are being used to restore the functional integrity of multiple neuroendocrine 
axes and thereby to better protect against the ravages of advancing age.
Because these novel interventions in aging have great potential value, practitioners 
are using them albeit, often without guidance and in isolation. Accordingly, as part of 
its service to Society members, SARA has established an interactive forum in which 
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society.com. The interactive forum will be open to all 
interested parties regardless of membership in the Society. 
However, only SARA members will be allowed to initiate 
new topics for discussion. Everyone is welcome to partake 
of these opportunities to exchange professional information 
either in print or online, and all are encouraged to participate 
in advancing the community base of knowledge in aging 
interventions.
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practitioners may ask questions about therapies or post com-
ments and report experiences which may be of help to their 
colleagues. The forum will be held at two locations. 
One site will be in a special section of each edition of 
CIA. Comments will consist of short essays describing obser-
vations, personal experiences, procedural questions or any 
other issue that will stimulate thought and comment about 
contemporary therapies for age-management. These may be 
submitted directly to the Editor at cia@dovepress.com who 
will review and edit each for publishing in the next edition 
of the Journal. It is intended that each submission will bring 
responses from other readers that may be used together in 
developing a more sound and logical approach to one speciﬁ  c 
treatment or another. Perhaps the result of such interactive 
exchange may be a manuscript summarizing certain issues 
and bringing consensus how they are best resolved.   
The second location for the interactive forum will be 
on-line at the new SARA website, http://www.ageresearch-